Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Involvement of cellular alternative splicing in the oncolytic potential of viruses for cancer therapy
FY 2022-23
Summary
Cancer is the leading cause of death in Canada, killing overall 1 in 4 Canadians. Although significant progress has been made in recent years in term of treatments, the search for new cancer therapies is an ongoing endeavour required to enhance both the survival of patients and provide new therapeutic opportunities with less secondary effects. Viruses that replicate preferentially in cancer cells to cause their destruction provide a new promising opportunity in our fight against cancer. Moreover, their activity is not solely based on their capacity to fight and destroy cancer cells. These viruses also present an important secondary advantage: they also stimulate the immune system of the patient, teaching it to fight back against the cancer if relapse occurs. However, even though initial clinical trials have generated promising results, larger clinical trials revealed limited efficacy of these viruses in most cases. Thus, more work is required to better understand the fundamental properties of these viruses and the factors that influence their potential as anticancer agents, so their efficacy can be improved. We propose to study the importance of regulation of RNA processing in the anticancer activity of these viruses. Dysregulations in RNA processing has been well documented in cancer for more than 20 years, and it is now clear that viruses alter RNA processing in cells to promote viral replication. Moreover, recent evidence suggests cancer-specific dysregulations in RNA processing are a therapeutic vulnerability that we believe can be harnessed, together with other anti-cancer activities of viruses to improve the treatment of cancer. This research proposal will potentially lead to new ways to enhance the therapeutic potential of viruses in the treatment of cancer based on the manipulation of RNA processing in cancer cells.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
Pennsylvania, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
471246
Name
Boudreault Simon
Region
Pennsylvania
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Involvement of cellular alternative splicing in the oncolytic potential of viruses for cancer therapy
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Alternative Splicing; Cancer; Oncolytic Virus; Patient Derived Xenograft; Rna-Sequencing; Sirna Screen; Spliceosomal Proteins; Spliceosome; Splicing; Splicing Factors
Abstract
Cancer is the leading cause of death in Canada, killing overall 1 in 4 Canadians. Although significant progress has been made in recent years in term of treatments, the search for new cancer therapies is an ongoing endeavour required to enhance both the survival of patients and provide new therapeutic opportunities with less secondary effects. Viruses that replicate preferentially in cancer cells to cause their destruction provide a new promising opportunity in our fight against cancer. Moreover, their activity is not solely based on their capacity to fight and destroy cancer cells. These viruses also present an important secondary advantage: they also stimulate the immune system of the patient, teaching it to fight back against the cancer if relapse occurs. However, even though initial clinical trials have generated promising results, larger clinical trials revealed limited efficacy of these viruses in most cases. Thus, more work is required to better understand the fundamental properties of these viruses and the factors that influence their potential as anticancer agents, so their efficacy can be improved. We propose to study the importance of regulation of RNA processing in the anticancer activity of these viruses. Dysregulations in RNA processing has been well documented in cancer for more than 20 years, and it is now clear that viruses alter RNA processing in cells to promote viral replication. Moreover, recent evidence suggests cancer-specific dysregulations in RNA processing are a therapeutic vulnerability that we believe can be harnessed, together with other anti-cancer activities of viruses to improve the treatment of cancer. This research proposal will potentially lead to new ways to enhance the therapeutic potential of viruses in the treatment of cancer based on the manipulation of RNA processing in cancer cells.
Competitiondate
202209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Boudreault, Simon
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~